Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

H1-antihistamines in the elderly.

Michael A Kaliner1

  • 1Institute for Allergy and Asthma, Wheaton, Maryland, USA.

Clinical Allergy and Immunology
|July 13, 2002
PubMed
Summary

Second-generation H1-antihistamines are safe and effective for elderly patients, offering a better alternative to first-generation options for allergies and skin conditions. Careful consideration of individual health needs and potential drug interactions is crucial for optimal treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Epinephrine Nasal Spray in the Treatment of Urticaria.

The journal of allergy and clinical immunology. In practice·2026
Same author

Pharmacokinetics and Pharmacodynamics of neffy, Epinephrine Nasal Spray, in Pediatric Allergy Patients.

The journal of allergy and clinical immunology. In practice·2025
Same author

Proposed mechanism of cardiovascular responses for bolus injection of epinephrine from epinephrine autoinjectors.

The journal of allergy and clinical immunology. In practice·2025
Same author

Rapid increases in epinephrine concentration following presumed intra-blood vessel administration via epinephrine autoinjector.

The journal of allergy and clinical immunology. Global·2023
Same author

Chapter 14: Nonallergic rhinitis.

American journal of rhinology & allergy·2017
Same author

Diagnosis and management of rhinosinusitis: a practice parameter update.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2014

Area of Science:

  • Geriatrics
  • Pharmacology
  • Allergy and Immunology

Background:

  • H1-antihistamine therapy is frequently used in the elderly for various allergic conditions and reactions.
  • First-generation antihistamines pose risks in older adults due to age-related physiological changes and potential drug interactions.

Purpose of the Study:

  • To evaluate the safety and efficacy of second-generation H1-receptor antagonists in the elderly population.
  • To provide guidance on antihistamine selection and management in older individuals.

Main Methods:

  • Review of current literature on H1-antihistamine use in geriatric patients.
  • Analysis of safety profiles, efficacy data, and pharmacokinetic considerations of different antihistamine generations.

Main Results:

  • Second-generation H1-antihistamines are safe and effective alternatives to first-generation agents in the elderly.
  • First-generation antihistamines should be avoided for allergic rhinitis and urticaria in this demographic.
  • Dosage adjustments may be necessary for certain agents in cases of renal or hepatic impairment.

Conclusions:

  • Second-generation H1-antihistamines are a preferred choice for managing allergic conditions in the elderly.
  • Individualized treatment plans considering comorbidities and concomitant medications are essential for safe and effective antihistamine therapy in older adults.

Related Experiment Videos